Basecamp Research

London AI drug-discovery company that trains models on large biological datasets to design therapeutics, including cell therapies.

View on the globe

$140MEquity raised in 2025–20262025 — · 2026 $140M · 1 equity round
$140MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 23 Sep 2026 to 23 Sep 2026, $140M equity disclosed. Earlier rounds exist but are not sourced.23 Sep 2026: Series C, $140M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yet← earlier rounds not sourcedQ2Q3Q42027Q2Equity round23 Sep 2026 · Series C · $140M · led by S32Series C · $140M
Funding history: 1 round from 23 Sep 2026 to 23 Sep 2026, $140M equity disclosed. Earlier rounds exist but are not sourced.23 Sep 2026: Series C, $140M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yetearlier rounds not sourcedQ2Q3Q42027Q2Equity round23 Sep 2026 · Series C · $140M · led by S32$140M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. Basecamp Research raised before 23 Sep 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series C
    Amount$140M
    Post-money—
    ✓ Confirmed
    Lead
    S32
    Also
    Menlo Ventures Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, Nvidia, PostScriptum, Redalpine, The Rockefeller Foundation, Singular VC, UK Sovereign AI Fund, True Ventures
    Note
    Company release (PR Newswire, London and Boston dateline, 23 Sep 2026; corrected version, the correction also dated 24 Sep): "$140M" oversubscribed Series C, lead S32, valuation not disclosed. Investor list is the release list. André Hoffmann (Vice-Chairman, Roche) is named individually in a separate sentence about additional pharma and industry investment, so he is left out (not a firm). The corrected release changes a headline and one paragraph; the original wording is not visible here.
    Sources
  2. Earlier rounds not yet sourced

Investors 15

  • S321
  • Catalio Capital Management
  • European Tech Collective
  • Firebrand River Capital
  • Inception Fund
  • King Philanthropies
  • Menlo Ventures Anthology Fund
  • NATO Innovation Fund
  • Nvidia
  • PostScriptum
  • Redalpine
  • Singular VC
  • The Rockefeller Foundation
  • True Ventures
  • UK Sovereign AI Fund

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the London hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Basecamp Research and its logo are trademarks of their owners, used here for identification only.